15-51737430-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_153374.3(LYSMD2):c.193G>A(p.Gly65Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000279 in 1,433,420 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G65V) has been classified as Uncertain significance.
Frequency
Consequence
NM_153374.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LYSMD2 | ENST00000267838.7 | c.193G>A | p.Gly65Ser | missense_variant | Exon 1 of 3 | 1 | NM_153374.3 | ENSP00000267838.3 | ||
LYSMD2 | ENST00000454181.6 | c.1-12309G>A | intron_variant | Intron 1 of 2 | 1 | ENSP00000410424.2 | ||||
LYSMD2 | ENST00000560491.2 | c.-1+410G>A | intron_variant | Intron 1 of 2 | 3 | ENSP00000453933.1 | ||||
LYSMD2 | ENST00000558126.1 | c.83-12439G>A | intron_variant | Intron 1 of 2 | 5 | ENSP00000452715.1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151778Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.00000234 AC: 3AN: 1281534Hom.: 0 Cov.: 33 AF XY: 0.00000158 AC XY: 1AN XY: 631042
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151886Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74274
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.193G>A (p.G65S) alteration is located in exon 1 (coding exon 1) of the LYSMD2 gene. This alteration results from a G to A substitution at nucleotide position 193, causing the glycine (G) at amino acid position 65 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at